Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0TM4K
|
||||
| Former ID |
DNC005633
|
||||
| Drug Name |
3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527456] | ||
| Formula |
C16H15N
|
||||
| Canonical SMILES |
CC1CC(=CC2=CN=CC=C2)C3=CC=CC=C13
|
||||
| InChI |
1S/C16H15N/c1-12-9-14(10-13-5-4-8-17-11-13)16-7-3-2-6-15(12)16/h2-8,10-12H,9H2,1H3/b14-10+
|
||||
| InChIKey |
KMRIBBKLCIMDTB-GXDHUFHOSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527456] | |
| NetPath Pathway | FSH Signaling Pathway | ||||
| PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
| PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
| Reactome | Endogenous sterols | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.